UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 140

Sortiert nach

New insights into diagnosis and therapeutic options for proliferative hepatoblastoma

Hepatology (Baltimore, Md.), 2018-07, Vol.68 (1), p.89-102

2018

Volltextzugriff (PDF)

Hepatitis B Virus Pregenomic RNA in Hepatocellular Carcinoma: A Nosological and Prognostic Determinant

Hepatology (Baltimore, Md.), 2018-01, Vol.67 (1), p.86-96

2018

Volltextzugriff (PDF)

Molecular classification of hepatoblastoma and prognostic value of the HB 16‐gene signature

Hepatology (Baltimore, Md.), 2017-10, Vol.66 (4), p.1351-1352

2017

Volltextzugriff (PDF)

Statements from the Taormina expert meeting on occult hepatitis B virus infection

Journal of hepatology, 2008-10, Vol.49 (4), p.652-657

2008

Volltextzugriff (PDF)

Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer

Proceedings of the National Academy of Sciences - PNAS, 2010-11, Vol.107 (47), p.20471-20476

2010

Volltextzugriff (PDF)

A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients

European journal of cancer (1990), 2020-12, Vol.141, p.30-39

2020

Volltextzugriff (PDF)

Methyltransferase PRMT1 Is a Binding Partner of HBx and a Negative Regulator of Hepatitis B Virus Transcription

Journal of Virology, 2013-04, Vol.87 (8), p.4360-4371

2013

Volltextzugriff (PDF)

Infectious agents and cancer: criteria for a causal relation

Seminars in cancer biology, 2004-12, Vol.14 (6), p.453-471

2004

Volltextzugriff (PDF)

LIM-Only Protein FHL2 Is a Negative Regulator of Transforming Growth Factor β1 Expression

Molecular and cellular biology, 2017-05, Vol.37 (10), p.e00636-16

2017

Volltextzugriff (PDF)

MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting β‐catenin and Wnt signaling

Hepatology communications, 2017-04, Vol.1 (2), p.168-183

2017

Volltextzugriff (PDF)

Mechanisms of HBV-related hepatocarcinogenesis

Journal of hepatology, 2010-04, Vol.52 (4), p.594-604

2010

Volltextzugriff (PDF)

Somatic Mutations of the β -catenin Gene are Frequent in Mouse and Human Hepatocellular Carcinomas

Proceedings of the National Academy of Sciences - PNAS, 1998-07, Vol.95 (15), p.8847-8851

1998

Volltextzugriff (PDF)

HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase

Journal of hepatology, 2015-11, Vol.63 (5), p.1093-1102

2015

Volltextzugriff (PDF)

Hepatocellular carcinoma

Cold Spring Harbor perspectives in medicine, 2015-02, Vol.5 (2), p.a021444-a021444

2015

Volltextzugriff (PDF)

Interaction and Functional Cooperation between the LIM Protein FHL2, CBP/p300, and β-Catenin

Molecular and Cellular Biology, 2004-12, Vol.24 (24), p.10689-10702

2004

Volltextzugriff (PDF)

Altered expression of E-cadherin in hepatocellular carcinoma: Correlations with genetic alterations, β-catenin expression, and clinical features

Hepatology (Baltimore, Md.), 2002-09, Vol.36 (3), p.692-701

2002

Volltextzugriff (PDF)

Polo‐like kinase 1 inhibition suppresses hepatitis B virus X protein‐induced transformation in an in vitro model of liver cancer progression

Hepatology (Baltimore, Md.), 2009-08, Vol.50 (2), p.414-423

2009

Volltextzugriff (PDF)

microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis

Gastroenterology (New York, N.Y. 1943), 2018-12, Vol.155 (6), p.1951-1966.e26

2018

Volltextzugriff (PDF)

Hepatitis B virus replicating in hepatocellular carcinoma encodes HBx variants with preserved ability to antagonize restriction by Smc5/6

Antiviral research, 2019-12, Vol.172, p.104618-104618, Article 104618

2019

Volltextzugriff (PDF)

The LIM-only Protein FHL2 Regulates Cyclin D1 Expression and Cell Proliferation

The Journal of biological chemistry, 2008-05, Vol.283 (22), p.15201-15208

2008

Volltextzugriff (PDF)

Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice

PloS one, 2010-04, Vol.5 (4), p.e10371

2010

Volltextzugriff (PDF)

TAK1 Suppresses a NEMO-Dependent but NF-κB-Independent Pathway to Liver Cancer

Cancer cell, 2010-05, Vol.17 (5), p.481-496

2010

Volltextzugriff (PDF)

Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer

Cancer cell, 2008-12, Vol.14 (6), p.471-484

2008

Volltextzugriff (PDF)

Diverse roles of hepatitis B virus in liver cancer

Current opinion in virology, 2012-08, Vol.2 (4), p.467-473

2012

Volltextzugriff (PDF)

Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma

Oncogene, 1999-05, Vol.18 (20), p.3127-3134

1999

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Life Sciences & Biomedicine
(82)
Humans
(64)
Animals
(63)
Biological And Medical Sciences
(35)
Tumors
(35)
Mice
(33)
Liver Neoplasms - Genetics
(32)
Life Sciences
(30)
Biochemistry & Molecular Biology
(29)
Hepatocellular Carcinoma
(27)
Carcinoma, Hepatocellular - Genetics
(24)
Oncology
(23)
Cell Biology
(22)
Gastroenterology & Hepatology
(21)
Liver Cancer
(21)
Medical Sciences
(21)
Base Sequence
(20)
Hepatitis B Virus
(20)
Virology
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

New insights into diagnosis and therapeutic options for proliferative hepatoblastoma

Hepatitis B Virus Pregenomic RNA in Hepatocellular Carcinoma: A Nosological and Prognostic Determinant

Molecular classification of hepatoblastoma and prognostic value of the HB 16‐gene signature

Statements from the Taormina expert meeting on occult hepatitis B virus infection

Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer

A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients

Methyltransferase PRMT1 Is a Binding Partner of HBx and a Negative Regulator of Hepatitis B Virus Transcription

Infectious agents and cancer: criteria for a causal relation

LIM-Only Protein FHL2 Is a Negative Regulator of Transforming Growth Factor β1 Expression

MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting β‐catenin and Wnt signaling

Mechanisms of HBV-related hepatocarcinogenesis

Somatic Mutations of the β -catenin Gene are Frequent in Mouse and Human Hepatocellular Carcinomas

HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase

Hepatocellular carcinoma

Interaction and Functional Cooperation between the LIM Protein FHL2, CBP/p300, and β-Catenin

Altered expression of E-cadherin in hepatocellular carcinoma: Correlations with genetic alterations, β-catenin expression, and clinical features

Polo‐like kinase 1 inhibition suppresses hepatitis B virus X protein‐induced transformation in an in vitro model of liver cancer progression

microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis

Hepatitis B virus replicating in hepatocellular carcinoma encodes HBx variants with preserved ability to antagonize restriction by Smc5/6

The LIM-only Protein FHL2 Regulates Cyclin D1 Expression and Cell Proliferation

Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice

TAK1 Suppresses a NEMO-Dependent but NF-κB-Independent Pathway to Liver Cancer

Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer

Diverse roles of hepatitis B virus in liver cancer

Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma

Suchergebnisse filtern